TITLE

Pharma Joins NGOs Against TB

PUB. DATE
December 2011
SOURCE
Pharmaceutical Representative;Dec2011, Vol. 41 Issue 12, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the collaboration of pharmaceutical companies including AstraZeneca PLC, Bayer AG, and Sanofi Aventis SA with the World Health Organization (WHO) to share information on tuberculosis (TB) compounds within their respective drug pipelines in the U.S.
ACCESSION #
69647444

 

Related Articles

  • CPTR Yields Progress: New Six-Way Agreement Among Pharmas and NGOs Will Speed Development of TB Drug Combinations.  // Biomedical Market Newsletter;11/14/2011, Vol. 21, p1062 

    The article reports on the innovative agreement between pharmaceutical companies, non-government organizations and regulatory agencies including AstraZeneca PLC, Bayer AG and World Health Organization that was developed through the cross-sector initiative Critical Path to Tuberculosis (TB) Drug...

  • CORPORATE.  // MondayMorning;11/4/2013, Vol. 21 Issue 40, p2 

    This section offers business news briefs as of November 4, 2013. Drug firm Pfizer raised its full-year forecast to 2.20 dollars a share after the company beat analysts' estimates on its third-quarter 2013 profit. A drop by 31 percent was seen in pharmaceutical company AstraZeneca's third-quarter...

  • Nektar Selling 19M Shares as Firm Goes Solo on NKTR-102. Boggs, Jennifer // BioWorld Today;1/20/2011, Vol. 22 Issue 13, p1 

    The article reports on the decision of Nektar Therapeutics Inc. to issue 19-million shares, which raised 234.5-million U.S. dollar on January 18, 2011. The company also disclosed previous to the share issuance that it will launch Phase III of its cancer drug NKTR-102, after initial positive data...

  • New in the Marketplace.  // Drugs & Therapy Perspectives;Oct2003, Vol. 19 Issue 10, p26 

    Presents a tabular representation of drug product launches and approvals in the international market as of October 2003. Insulin glargine from Aventis; Rosuvastatin from AstraZeneca; Tegaserod from Novartis Pharma; Vardenafil from Bayer AG and GlaxoSmithKline.

  • Pink Slips.  // Pharmaceutical Executive;Dec2007, Vol. 27 Issue 12, p24 

    The article cites a tally showing which pharmaceutical companies are making the greatest workforce changes. Pfizer Inc. (PI) tops the list as it cuts 10 percent of its workforce. PI closes three research centers and two manufacturing plants. AstraZeneca PLC sheds 11 percent, mostly from its...

  • Pharmaceutical Company Round-up.  // PharmaWatch: Monthly Review;September 2004, Vol. 3 Issue 9, p3 

    Reports on news and developments concerning the pharmaceutical industry. Consumer protection group, Public Citizen's call for a criminal investigation of AstraZeneca to determine whether it delayed the disclosure of adverse reactions to its cholesterol drug, Crestol; Eli Lilly & Co.'s voluntary...

  • Big pharma thins out ranks. Mirasol, Feliza // ICIS Chemical Business Americas;3/12/2007, Vol. 271 Issue 10, p34 

    The article deals with the restructuring efforts of several pharmaceutical companies industry to improve their financial performance. Bayer has announced that it is cutting an estimated 6,100 jobs worldwide. Pfizer has also announced that it is having a 20% job cut in its U.S. sales force. In...

  • Turkey Pharmaceuticals and Healthcare Report Q3 2012.  // Biomedical Market Newsletter;6/18/2012, Vol. 21, p1 

    The article informs that Research & Markets Ltd. has added the report "Turkey Pharmaceuticals and Healthcare Report Q3 2012" to their offering. According to the report, Turkey's pharmaceutical market growth was driven by modernization, growing investment and improving awareness about healthcare....

  • Drug Delivery in Germany.  // Drug Delivery Industry Profile: Germany;November 2004, p1 

    Presents a profile of the Drug Delivery industry in Germany. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics